Meriggioli MN - Search Results

1

Etanercept treatment in corticosteroid-dependent myasthenia gravis.

Rowin J, Meriggioli MN, Tüzün E, Leurgans S, Christadoss P. Rowin J, et al. Among authors: meriggioli mn. Neurology. 2004 Dec 28;63(12):2390-2. doi: 10.1212/01.wnl.0000147242.92691.71. Neurology. 2004. PMID: 15623708 Clinical Trial.

2

Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study.

Meriggioli MN, Rowin J, Richman JG, Leurgans S. Meriggioli MN, et al. Ann N Y Acad Sci. 2003 Sep;998:494-9. doi: 10.1196/annals.1254.064. Ann N Y Acad Sci. 2003. PMID: 14592919 Clinical Trial.

3

Single fiber EMG as an outcome measure in myasthenia gravis: results from a double-blind, placebo-controlled trial.

Meriggioli MN, Rowin J. Meriggioli MN, et al. J Clin Neurophysiol. 2003 Sep-Oct;20(5):382-5. doi: 10.1097/00004691-200309000-00011. J Clin Neurophysiol. 2003. PMID: 14702000 Clinical Trial.

4

Treatment of myasthenia gravis with mycophenolate mofetil: a case report.

Meriggioli MN, Rowin J. Meriggioli MN, et al. Muscle Nerve. 2000 Aug;23(8):1287-9. doi: 10.1002/1097-4598(200008)23:8<1287::aid-mus22>3.0.co;2-l. Muscle Nerve. 2000. PMID: 10918271

5

Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.

Meriggioli MN, Ciafaloni E, Al-Hayk KA, Rowin J, Tucker-Lipscomb B, Massey JM, Sanders DB. Meriggioli MN, et al. Neurology. 2003 Nov 25;61(10):1438-40. doi: 10.1212/01.wnl.0000094122.88929.0b. Neurology. 2003. PMID: 14638974

6

Mycophenolate mofetil in dermatomyositis: is it safe?

Rowin J, Amato AA, Deisher N, Cursio J, Meriggioli MN. Rowin J, et al. Among authors: meriggioli mn. Neurology. 2006 Apr 25;66(8):1245-7. doi: 10.1212/01.wnl.0000208416.32471.c0. Neurology. 2006. PMID: 16636243

7

Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment.

Tüzün E, Meriggioli MN, Rowin J, Yang H, Christadoss P. Tüzün E, et al. Among authors: meriggioli mn. J Autoimmun. 2005 May;24(3):261-8. doi: 10.1016/j.jaut.2005.01.013. J Autoimmun. 2005. PMID: 15848049 Clinical Trial.

8

Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.

Tüzün E, Saini SS, Ghosh S, Rowin J, Meriggioli MN, Christadoss P. Tüzün E, et al. Among authors: meriggioli mn. Neuromuscul Disord. 2006 Feb;16(2):137-43. doi: 10.1016/j.nmd.2005.11.005. Epub 2006 Jan 19. Neuromuscul Disord. 2006. PMID: 16427283

9

Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low/-) T cells in patients with myasthenia gravis.

Thiruppathi M, Rowin J, Ganesh B, Sheng JR, Prabhakar BS, Meriggioli MN. Thiruppathi M, et al. Among authors: meriggioli mn. Clin Immunol. 2012 Dec;145(3):209-23. doi: 10.1016/j.clim.2012.09.012. Epub 2012 Oct 7. Clin Immunol. 2012. PMID: 23110942 Free PMC article.

10

Functional defect in regulatory T cells in myasthenia gravis.

Thiruppathi M, Rowin J, Li Jiang Q, Sheng JR, Prabhakar BS, Meriggioli MN. Thiruppathi M, et al. Among authors: meriggioli mn. Ann N Y Acad Sci. 2012 Dec;1274(1):68-76. doi: 10.1111/j.1749-6632.2012.06840.x. Ann N Y Acad Sci. 2012. PMID: 23252899 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters